Selective antifolates for chemically labeling proteins in mammalian cells.
作者信息
Pedró Rosa Laura E, Reddy D Rajasekhar, Queener Sherry F, Miller Lawrence W
机构信息
Department of Chemistry, University of Illinois at Chicago, 845 W. Taylor Street, MC111, Chicago, IL 60607, USA.
出版信息
Chembiochem. 2009 Jun 15;10(9):1462-4. doi: 10.1002/cbic.200900152.
Abstract
摘要
相似文献
1
Selective antifolates for chemically labeling proteins in mammalian cells.
Chembiochem. 2009 Jun 15;10(9):1462-4. doi: 10.1002/cbic.200900152.
2
DNA and RNA synthesis: antifolates.
Chem Rev. 2005 Feb;105(2):593-620. doi: 10.1021/cr0301144.
3
Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates.
Chem Biol Drug Des. 2009 Sep;74(3):322-6. doi: 10.1111/j.1747-0285.2009.00860.x.
4
Towards new antifolates targeting eukaryotic opportunistic infections.
Eukaryot Cell. 2009 Apr;8(4):483-6. doi: 10.1128/EC.00298-08. Epub 2009 Jan 23.
5
Structural analysis of dihydrofolate reductases enables rationalization of antifolate binding affinities and suggests repurposing possibilities.
FEBS J. 2016 Mar;283(6):1139-67. doi: 10.1111/febs.13662. Epub 2016 Feb 25.
6
The molecular perspective: methotrexate.
Stem Cells. 1999;17(5):314-5. doi: 10.1002/stem.170314.
7
Eukaryotic dihydrofolate reductase.
Adv Enzymol Relat Areas Mol Biol. 1995;70:23-102. doi: 10.1002/9780470123164.ch2.
8
Basis for antifolate action and resistance in malaria.
Microbes Infect. 2002 Feb;4(2):175-82. doi: 10.1016/s1286-4579(01)01525-8.
9
A general chemical method to regulate protein stability in the mammalian central nervous system.
Chem Biol. 2010 Sep 24;17(9):981-8. doi: 10.1016/j.chembiol.2010.07.009.
10
Regulation of human dihydrofolate reductase activity and expression.
Vitam Horm. 2008;79:267-92. doi: 10.1016/S0083-6729(08)00409-3.
本文引用的文献
1
Conditional glycosylation in eukaryotic cells using a biocompatible chemical inducer of dimerization.
J Am Chem Soc. 2008 Oct 8;130(40):13186-7. doi: 10.1021/ja8037728. Epub 2008 Sep 13.
2
Optimized fluorescent trimethoprim derivatives for in vivo protein labeling.
Chembiochem. 2007 May 7;8(7):767-74. doi: 10.1002/cbic.200600414.
3
An orthogonal dexamethasone-trimethoprim yeast three-hybrid system.
Anal Biochem. 2007 Apr 1;363(1):160-2. doi: 10.1016/j.ab.2006.12.013. Epub 2006 Dec 28.
4
New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
Proteins. 2006 Dec 1;65(4):959-69. doi: 10.1002/prot.21131.
5
Towards species-specific antifolates.
Curr Med Chem. 2006;13(4):377-98. doi: 10.2174/092986706775527938.
6
A simple dual selection for functionally active mutants of Plasmodium falciparum dihydrofolate reductase with improved solubility.
Protein Eng Des Sel. 2005 Oct;18(10):457-64. doi: 10.1093/protein/gzi044. Epub 2005 Aug 24.
7
In vivo protein labeling with trimethoprim conjugates: a flexible chemical tag.
Nat Methods. 2005 Apr;2(4):255-7. doi: 10.1038/nmeth749.
8
DNA and RNA synthesis: antifolates.
Chem Rev. 2005 Feb;105(2):593-620. doi: 10.1021/cr0301144.
9
Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium.
Bioorg Med Chem Lett. 2004 Apr 5;14(7):1811-5. doi: 10.1016/j.bmcl.2003.12.103.
10
Target guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum.
J Med Chem. 2004 Jan 15;47(2):345-54. doi: 10.1021/jm0303352.
Zotero 插件